JL

Jitendrabhai Lalajibhai Lakhani

Active Director Managing Director DIN 06747443
DIN 06747443 First appointment Jan 2014 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Total affiliations 5 Since Jan 2014
Shareholding value •••• Premium profile

About Jitendrabhai Lalajibhai Lakhani

Data last updated:

Jitendrabhai Lalajibhai Lakhani is a Managing Director at Nilrise Pharmaceuticals Private Limited (since 2014), Director at Crinova Healthcare Private Limited (since 2019) and Director at Irenic Capitals Private Limited (since 2022), and holds 2 more current directorships. The companies operate in Pharma, Financial Services and Home & Lifestyle. The 5 current companies with reported revenue have a combined latest revenue of ₹19.81 Cr; the largest is Nilrise Pharmaceuticals Private Limited at ₹10.92 Cr (FY 2025).

DIN 06747443
Primary Designation Managing Director
Industry Pharma
First Appointment 09 Jan 2014
Oldest Company Age 12 yrs
Largest company Nilrise Pharmaceuticals Private Limited · ₹10.92 Cr (FY 2025)
Combined revenue ₹19.81 Cr across 5 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Managing Director09 Jan 20142014₹10.92 Cr (FY 2025)Active
Crinova Healthcare Private Limited U51909GJ2019PTC107891
Director30 Apr 20192019₹7.29 Cr (FY 2025)Active
Irenic Capitals Private Limited U65990GJ2022PTC129614
Director23 Feb 20222022₹78.5 Lakh (FY 2025)Active
Director17 Dec 20202020₹76.6 Lakh (FY 2025)Active
Opurik Innovation Private Limited U72900GJ2022PTC135713
Director23 Sep 20222022₹4.7 Lakh (FY 2025)Active

Directorship timeline

Open interactive timeline →
Healthiza Lifescience Private Limited
Nilrise Pharmaceuticals Private Limited
Crinova Healthcare Private Limited
Irenic Capitals Private Limited
Premium access

Shareholding and investment profile for Jitendrabhai Lalajibhai Lakhani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jitendrabhai Lalajibhai Lakhani

Jitendrabhai Lalajibhai Lakhani currently holds 5 directorships: Nilrise Pharmaceuticals Private Limited (Managing Director, since 09 Jan 2014, revenue ₹10.92 Cr (FY 2025)); Crinova Healthcare Private Limited (Director, since 30 Apr 2019, revenue ₹7.29 Cr (FY 2025)); Irenic Capitals Private Limited (Director, since 23 Feb 2022, revenue ₹78.5 Lakh (FY 2025)); Healthiza Lifescience Private Limited (Director, since 17 Dec 2020, revenue ₹76.6 Lakh (FY 2025)); Opurik Innovation Private Limited (Director, since 23 Sep 2022, revenue ₹4.7 Lakh (FY 2025)).

Jitendrabhai Lalajibhai Lakhani was first appointed on 09 Jan 2014 as Managing Director at Nilrise Pharmaceuticals Private Limited. The most recent appointment on record is 23 Sep 2022 at Opurik Innovation Private Limited.

The 5 current companies of Jitendrabhai Lalajibhai Lakhani that report revenue have a combined latest revenue of ₹19.81 Cr: Nilrise Pharmaceuticals Private Limited ₹10.92 Cr (FY 2025); Crinova Healthcare Private Limited ₹7.29 Cr (FY 2025); Irenic Capitals Private Limited ₹78.5 Lakh (FY 2025); Healthiza Lifescience Private Limited ₹76.6 Lakh (FY 2025); Opurik Innovation Private Limited ₹4.7 Lakh (FY 2025).

The current boards of Jitendrabhai Lalajibhai Lakhani's companies include Hardikkumar Kalubhai Vaghasiya (Nilrise Pharmaceuticals Private Limited), Hiral Jitendrabhai Lakhani (Nilrise Pharmaceuticals Private Limited), Parth Hareshbhai Kalathiya (Crinova Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available